Benedikt Simbrunner

3.3k total citations · 1 hit paper
104 papers, 1.6k citations indexed

About

Benedikt Simbrunner is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Benedikt Simbrunner has authored 104 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Hepatology, 88 papers in Epidemiology and 26 papers in Surgery. Recurrent topics in Benedikt Simbrunner's work include Liver Disease Diagnosis and Treatment (84 papers), Liver Disease and Transplantation (82 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Benedikt Simbrunner is often cited by papers focused on Liver Disease Diagnosis and Treatment (84 papers), Liver Disease and Transplantation (82 papers) and Organ Transplantation Techniques and Outcomes (19 papers). Benedikt Simbrunner collaborates with scholars based in Austria, Netherlands and United Kingdom. Benedikt Simbrunner's co-authors include Thomas Reiberger, Michael Trauner, Mattias Mandorfer, David Bauer, Bernhard Scheiner, Rafael Paternostro, Georg Semmler, Lukas Hartl, Philipp Schwabl and Mathias Jachs and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Benedikt Simbrunner

92 papers receiving 1.6k citations

Hit Papers

Bile acid metabolism and signalling in liver disease 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benedikt Simbrunner Austria 24 1.2k 1.2k 401 139 117 104 1.6k
Georg Semmler Austria 24 1.2k 1.0× 940 0.8× 406 1.0× 100 0.7× 137 1.2× 141 1.7k
Vincenzo La Mura Italy 25 1.7k 1.4× 1.5k 1.3× 506 1.3× 137 1.0× 103 0.9× 75 2.1k
Rafael Paternostro Austria 24 1.3k 1.1× 1.2k 1.0× 422 1.1× 127 0.9× 169 1.4× 80 1.8k
Albert Friedrich Stättermayer Austria 27 1.6k 1.3× 1.6k 1.4× 325 0.8× 105 0.8× 40 0.3× 94 2.3k
Paul Manka Germany 19 695 0.6× 621 0.5× 186 0.5× 181 1.3× 92 0.8× 59 1.1k
Sanjiv Saigal India 20 807 0.7× 932 0.8× 647 1.6× 66 0.5× 63 0.5× 121 1.4k
Manuel de la Mata Spain 20 692 0.6× 916 0.8× 409 1.0× 201 1.4× 75 0.6× 53 1.4k
Ming‐Chih Hou Taiwan 23 802 0.7× 994 0.9× 615 1.5× 114 0.8× 54 0.5× 105 1.5k
Ahmad H. Ali United States 17 867 0.7× 945 0.8× 690 1.7× 177 1.3× 82 0.7× 58 1.6k
Federica Botta Italy 20 1.6k 1.4× 1.5k 1.3× 536 1.3× 82 0.6× 108 0.9× 40 2.1k

Countries citing papers authored by Benedikt Simbrunner

Since Specialization
Citations

This map shows the geographic impact of Benedikt Simbrunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedikt Simbrunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedikt Simbrunner more than expected).

Fields of papers citing papers by Benedikt Simbrunner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benedikt Simbrunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedikt Simbrunner. The network helps show where Benedikt Simbrunner may publish in the future.

Co-authorship network of co-authors of Benedikt Simbrunner

This figure shows the co-authorship network connecting the top 25 collaborators of Benedikt Simbrunner. A scholar is included among the top collaborators of Benedikt Simbrunner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benedikt Simbrunner. Benedikt Simbrunner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simbrunner, Benedikt, Michael Schwarz, Lukas Hartl, et al.. (2025). Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis. Liver International. 45(10). e70314–e70314. 1 indexed citations
2.
Hofer, Benedikt, Lorenz Balcar, Mathias Schneeweiss‐Gleixner, et al.. (2025). Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure. Liver International. 45(10). e70363–e70363.
3.
Jachs, Mathias, Lukas Hartl, Michael Schwarz, et al.. (2025). Diagnostic and Clinical Implications of High Spleen‐To‐Liver Stiffness Ratio in MASH —A Prospective, Comparative Study. Liver International. 45(10). e70261–e70261.
4.
Jachs, Mathias, Lukas Hartl, Benedikt Simbrunner, et al.. (2024). Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. Journal of Hepatology. 80(5). 744–752. 19 indexed citations
5.
Semmler, Georg, Sarah Shalaby, Juan Sánchez-Ávila, et al.. (2024). Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals. JHEP Reports. 6(12). 101208–101208. 2 indexed citations
6.
Schwarz, Michael, Benedikt Simbrunner, Mathias Jachs, et al.. (2024). High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease. Liver International. 44(11). 2904–2914. 3 indexed citations
7.
Scheiner, Bernhard, Alberto Zanetto, Lorenz Balcar, et al.. (2024). Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease. Alimentary Pharmacology & Therapeutics. 59(11). 1376–1386. 3 indexed citations
8.
Hartl, Lukas, Michael Schwarz, Benedikt Simbrunner, et al.. (2024). Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality. Alimentary Pharmacology & Therapeutics. 61(1). 88–98. 4 indexed citations
10.
Balcar, Lorenz, Benedikt Simbrunner, Rafael Paternostro, et al.. (2023). Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD. JHEP Reports. 6(1). 100934–100934. 2 indexed citations
11.
Hofer, Benedikt, Benedikt Simbrunner, Lukas Hartl, et al.. (2023). Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis. Liver International. 43(10). 2220–2231. 36 indexed citations
12.
Hartl, Lukas, Benedikt Simbrunner, Mathias Jachs, et al.. (2023). Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality. JHEP Reports. 6(1). 100954–100954. 2 indexed citations
13.
Balcar, Lorenz, Bernhard Scheiner, Rafael Paternostro, et al.. (2023). Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease. JHEP Reports. 5(4). 100682–100682. 13 indexed citations
14.
Scheiner, Bernhard, Lorenz Balcar, Rafael Paternostro, et al.. (2022). Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Journal of Hepatology. 76(5). 1090–1099. 24 indexed citations
15.
Hartl, Lukas, Mathias Jachs, Benedikt Simbrunner, et al.. (2021). Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. Journal of Personalized Medicine. 11(12). 1264–1264. 8 indexed citations
16.
Hartl, Lukas, Georg Semmler, Benedikt Hofer, et al.. (2021). COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality. Hepatology Communications. 5(10). 1660–1675. 20 indexed citations
17.
Jachs, Mathias, Lukas Hartl, Benedikt Simbrunner, et al.. (2020). Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut. 70(9). 1758–1767. 58 indexed citations
18.
Beer, Lucian, Nina Bastati, Ahmed Ba‐Ssalamah, et al.. (2020). MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease. Liver International. 40(11). 2797–2807. 28 indexed citations
19.
Scheiner, Bernhard, Albert Friedrich Stättermayer, Philipp Schwabl, et al.. (2019). Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. Liver International. 40(2). 393–404. 17 indexed citations
20.
Semmler, Georg, Benedikt Simbrunner, Bernhard Scheiner, et al.. (2019). Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension. Journal of Gastroenterology and Hepatology. 34(12). 2164–2172. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026